MICHELLE CANTU: Open Payments
NPI 1710167333 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,715 in 154 payments from 18 companies in 2025. Trend: 2023 $2,614 · 2024 $2,582 · 2025 $2,715
Food & beverage: $2,715
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 28 | $494 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $450 |
| Otsuka America Pharmaceutical, Inc. | 26 | $312 |
| Janssen Pharmaceuticals, Inc | 14 | $304 |
| Alkermes, Inc. | 13 | $269 |
| Lundbeck LLC | 13 | $254 |
| Teva Pharmaceuticals USA, Inc. | 6 | $133 |
| Noven Therapeutics, LLC | 4 | $88 |
| Almatica Pharma LLC | 4 | $70 |
| Bausch Health US, LLC | 4 | $69 |
Products named: REXULTI, CAPLYTA, Auvelity, SPRAVATO, ARISTADA, Sunosi, UZEDY, Xelstrym.
Industry payments across TX — which companies pay providers there.
